Neurodevelopmental disorder with language impairment and behavioral abnormalities: genes and variants
Explore variant evidence for Neurodevelopmental disorder with language impairment and behavioral abnormalities across 1 analyzed protein (GRIA2). Linked ClinVar records include 24 pathogenic or likely pathogenic variants, 16 variants of uncertain significance and 2 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Neurodevelopmental disorder with language impairment and behavioral abnormalities
GRIA2: Glutamate receptor 2
An AMPA-type glutamate receptor subunit that contributes to fast excitatory signaling in the nervous system. Together with other subunits it forms a glutamate-gated cation channel, and its presence helps shape the channel's ion permeability and synaptic behavior.
24 ClinVar pathogenic / likely pathogenic and 18 uncertain variants in GRIA2 have source records linked to Neurodevelopmental disorder with language impairment and behavioral abnormalities. Association strength is not clinical gene validity.
Where Neurodevelopmental disorder with language impairment and behavioral abnormalities variants cluster
- GRIA2 Extracellular (positions 638–812): 14 of 23 ClinVar pathogenic / likely pathogenic variants, 3.1× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Neurodevelopmental disorder with language impairment and behavioral abnormalities
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GRIA2 A639S | 639 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GRIA2 T646N | 646 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GRIA2 G792E | 792 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GRIA2 A807V | 807 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GRIA2 V647A | 647 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 V647L | 647 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 A639G | 639 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 A643T | 643 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 F644L | 644 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 G792V | 792 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 R620H | 620 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIA2 D302G | 302 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 S522C | 522 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 P528T | 528 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 K530M | 530 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 G556E | 556 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIA2 Q607E | 607 | Helical | Pathogenic / likely pathogenic (★) |
| GRIA2 G609R | 609 | Intramembrane | Pathogenic / likely pathogenic (★) |
| GRIA2 N730Y | 730 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 G745V | 745 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 K751E | 751 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 W788L | 788 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 N812S | 812 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIA2 F628S | 628 | Transmembrane | Pathogenic / likely pathogenic |
Which prediction tools work for Neurodevelopmental disorder with language impairment and behavioral abnormalities
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 99 out of 100
- ESM1b (LLR): 97 out of 100
- SIFT: 94 out of 100
- CATVariant: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Neurodevelopmental disorder with language impairment and behavioral abnormalities
- Epilepsy, also linked to GRIA2
- Migraine, also linked to GRIA2
- Lennox-Gastaut syndrome, also linked to GRIA2
Frequently asked questions
Which genes have records linked to Neurodevelopmental disorder with language impairment and behavioral abnormalities?
This view contains 1 analyzed proteins: GRIA2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 24 pathogenic or likely pathogenic variants, 16 variants of uncertain significance and 2 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 47 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center